Quantifying the broader economic consequences of quadrivalent human papillomavirus (HPV) vaccination in Germany applying a government perspective framework
Year of publication: |
December 2015
|
---|---|
Authors: | Kotsopoulos, Nikolaos ; Connolly, Mark P. ; Remy, Vanessa |
Subject: | Human papillomavirus | Fiscal analysis | Cost-benefit analysis | Vaccination | Germany | Microeconomics | Lifetime modelling | Deutschland | Impfung | Kosten-Nutzen-Analyse | Arzneimittel | Pharmaceuticals |
Type of publication: | Article |
---|---|
Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
Language: | English |
Other identifiers: | 10.1186/s13561-015-0054-6 [DOI] hdl:10419/150503 [Handle] |
Classification: | H7 - State and Local Government; Intergovernmental Relations ; H51 - Government Expenditures and Health ; H57 - Procurement ; I12 - Health Production: Nutrition, Mortality, Morbidity, Substance Abuse and Addiction, Disability, and Economic Behavior ; I18 - Government Policy; Regulation; Public Health |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Kotsopoulos, Nikolaos, (2015)
-
The benefits and costs of U.S. employer COVID-19 vaccine mandates
Ferranna, Maddalena, (2022)
-
Lee, Peter, (2022)
- More ...
-
Kotsopoulos, Nikolaos, (2015)
-
Connolly, Mark P., (2017)
-
Sustainability of public finances : inclusion of unrelated medical cost only part of the story
Connolly, Mark P., (2019)
- More ...